GUFICBIO — Gufic Biosciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual income statement for Gufic Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,788	4,877	7,792	6,906	8,067
Cost of Revenue
Gross Profit	1,806	2,155	3,376	3,264	3,793
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,403	4,201	6,506	5,753	6,755
Operating Profit	385	676	1,286	1,153	1,312
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	301	577	1,268	1,067	1,157
Provision for Income Taxes
Net Income After Taxes	227	442	958	797	861
Net Income Before Extraordinary Items
Net Income	227	442	958	797	861
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	227	442	958	797	861
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.34	4.56	9.88	8.22	8.92
Dividends per Share